Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 3 1

Status

Active not recruiting 6Unknown 2Recruiting 2Withdrawn 1Completed 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Rectal Neoplasms 1Colorectal Neoplasms 1Colorectal Adenoma 1Colonic Neoplasms 1

Interventions

Oxaliplatin 288Capecitabine 218Fluorouracil 212Irinotecan 145Leucovorin 139Gemcitabine 124S 1 (combination) 110apatinib 109Cisplatin 102Drug Therapy 98Bevacizumab 98Radiotherapy 97Paclitaxel 97camrelizumab 89sintilimab 79Cetuximab 75lenvatinib 62Neoadjuvant Therapy 61tislelizumab 55Surgical Procedures, Operative 54Sorafenib 53Folfox protocol 53toripalimab 52Docetaxel 52130-nm albumin-bound paclitaxel 47Laparoscopy 41HMPL-013 40XELOX 39Radiosurgery 36Albumin-Bound Paclitaxel 36

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Sigmoidoscopy × Gastrointestinal × Clear all
NCT00893295 2013-12-18

Increasing Colorectal Cancer Screening in African Americans

National Cancer Institute (NCI)

Phase 3 Unknown
896 enrolled
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT01767870 2013-01-14

FITS

Yonsei University

Phase 4 Unknown
5,282 enrolled
Gastrointestinal

Colorectal Adenoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡